BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15690642)

  • 1. Minimal residual disease studies in acute leukemia.
    Campana D
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S47-57. PubMed ID: 15690642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of minimal residual disease evaluation in leukemia therapy.
    Campana D
    Curr Hematol Malig Rep; 2008 Jul; 3(3):155-60. PubMed ID: 20425460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
    Huang YJ; Coustan-Smith E; Kao HW; Liu HC; Chen SH; Hsiao CC; Yang CP; Jaing TH; Yeh TC; Kuo MC; Lai CL; Chang CH; Campana D; Liang DC; Shih LY
    J Formos Med Assoc; 2017 Oct; 116(10):774-781. PubMed ID: 28063722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia.
    Gaipa G; Basso G; Biondi A; Campana D
    Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease as a surrogate marker for risk assignment to ALL patients.
    Cazzaniga G; Gaipa G; Rossi V; Biondi A
    Rev Clin Exp Hematol; 2003 Sep; 7(3):292-323. PubMed ID: 15024971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease studies by flow cytometry in acute leukemia.
    Campana D; Coustan-Smith E
    Acta Haematol; 2004; 112(1-2):8-15. PubMed ID: 15178999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology.
    Cazzaniga G; Biondi A
    Haematologica; 2005 Mar; 90(3):382-90. PubMed ID: 15749670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of minimal residual disease in acute leukemia.
    van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
    J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of minimal residual disease in acute leukemia by multiparametric flow cytometry.
    Kusenda J; Fajtova M; Kovarikova A
    Neoplasma; 2014; 61(2):119-27. PubMed ID: 24299307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction.
    Drexler HG; Borkhardt A; Janssen JW
    Leuk Lymphoma; 1995 Nov; 19(5-6):359-80. PubMed ID: 8590836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PCR technology for detecting minimal residual disease in patients with leukemia.
    Radich JP
    Rev Immunogenet; 1999; 1(2):265-78. PubMed ID: 11253952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in acute leukemia patients.
    van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
    Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
    van Dongen JJ; Macintyre EA; Gabert JA; Delabesse E; Rossi V; Saglio G; Gottardi E; Rambaldi A; Dotti G; Griesinger F; Parreira A; Gameiro P; Diáz MG; Malec M; Langerak AW; San Miguel JF; Biondi A
    Leukemia; 1999 Dec; 13(12):1901-28. PubMed ID: 10602411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress of minimal residual disease studies in childhood acute leukemia.
    Campana D
    Curr Hematol Malig Rep; 2010 Jul; 5(3):169-76. PubMed ID: 20467922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in acute leukemia by flow cytometry.
    Campana D; Coustan-Smith E
    Cytometry; 1999 Aug; 38(4):139-52. PubMed ID: 10440852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing for Minimal Residual Disease Surveillance in Acute Lymphoblastic Leukemia: An Update.
    Reyes-Barron C; Burack WR; Rothberg PG; Ding Y
    Crit Rev Oncog; 2017; 22(5-6):559-567. PubMed ID: 29604931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
    Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
    Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
    Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
    Neale GA; Coustan-Smith E; Stow P; Pan Q; Chen X; Pui CH; Campana D
    Leukemia; 2004 May; 18(5):934-8. PubMed ID: 15029212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease in acute lymphoblastic leukemia.
    Campana D
    Hematology Am Soc Hematol Educ Program; 2010; 2010():7-12. PubMed ID: 21239764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.